SCHEMBL21788015

SCHEMBL21788015

O=C(c1ccc(-c2ccc(C(=O)N(CCO)CCO)cc2)cc1)N(CCO)CCO

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
HPGD P15428 3/20 0.53
MAPT P10636 1/20 0.53
GAA P10253 1/20 0.49
GABRA1 P14867 1/20 0.46
GABRB2 P47870 1/20 0.46
MLYCD O95822 2/20 0.44
NPC1 O15118 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LIMK2 P53671 1/20 0.43
EGFR P00533 2/20 0.42
ERBB2 P04626 2/20 0.42
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
HDAC4 P56524 1/20 0.39
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7157289 0.93 ALDH1A1 (0.48) ALDH1A1HPGDMAPTGAAGABRA1
SCHEMBL17305019 0.92 ALDH1A1 (0.47) ALDH1A1HPGDMAPTGAAGABRA1
SCHEMBL9564988 0.85 ALDH1A1 (0.50) ALDH1A1HPGDMAPTGAAMLYCD
SCHEMBL5664687 0.83 ALDH1A1 (0.42) ALDH1A1HPGDMAPTMLYCDNPC1
SCHEMBL19835578 0.83 ALDH1A1 (0.64) ALDH1A1MAPTMLYCDNPC1L3MBTL1
SCHEMBL27369242 0.83 TPMT (0.45) ALDH1A1HPGDMAPTMLYCDNPC1
SCHEMBL14117677 0.83 CYP3A4 (0.43) ALDH1A1HPGDMAPTMLYCDNPC1
SCHEMBL7456186 0.83 ALDH1A1 (0.46) ALDH1A1HPGDMAPTGAAMLYCD
SCHEMBL17305016 0.83 POLB (0.53) ALDH1A1HPGDMLYCDNPC1L3MBTL1
SCHEMBL154607 0.83 HPGD (0.53) ALDH1A1HPGDMAPTGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11781071-B2 Cross-linking agent compound, liquid crystal alignment composition comprising the same, method of preparing liquid crystal alignment film, and liquid crystal alignment film and liquid crystal display using the same LG CHEM, LTD. (KR) 2023-10-10 US disclosed
US-11781071-B2 Cross-linking agent compound, liquid crystal alignment composition comprising the same, method of preparing liquid crystal alignment film, and liquid crystal alignment film and liquid crystal display using the same LG CHEM, LTD. (KR) 2023-10-10 US disclosed
US-11754921-B2 Crosslinking agent compound, photosensitive composition comprising the same, and photosensitive material using the same LG CHEM, LTD. (KR) 2023-09-12 US disclosed
US-11754921-B2 Crosslinking agent compound, photosensitive composition comprising the same, and photosensitive material using the same LG CHEM, LTD. (KR) 2023-09-12 US disclosed
WO-2023085390-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2023-05-19 WO disclosed
US-20210122979-A1 CROSS-LINKING AGENT COMPOUND, LIQUID CRYSTAL ALIGNMENT COMPOSITION COMPRISING THE SAME, METHOD OF PREPARING LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY USING THE SAME LG CHEM, LTD. (KR) 2021-04-29 US disclosed
US-20210061976-A1 CROSSLINKING AGENT COMPOUND, PHOTOSENSITIVE COMPOSITION COMPRISING THE SAME, AND PHOTOSENSITIVE MATERIAL USING THE SAME LG CHEM, LTD. (KR) 2021-03-04 US disclosed
WO-2020145175-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2020-07-16 WO disclosed
WO-2020138259-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, LIQUID CRYSTAL DISPLAY ELEMENT, AND NOVEL MONOMER 日産化学株式会社 2020-07-02 WO disclosed
WO-2020116459-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2020-06-11 WO disclosed
WO-2020045549-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2020-03-05 WO disclosed
WO-2020045548-A1 METHOD FOR PRODUCING LIQUID CRYSTAL ALIGNMENT FILM, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2020-03-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11781071-B2 Cross-linking agent compound, liquid crystal alignment composition comprising the same, method of preparing liquid crystal alignment film, and liquid crystal alignment film and liquid crystal display using the same LPXN, LIG4, MACF1 ALDH1A1 4249/4885HPGD 4697/4885MAPT 214/4885
US-20210122979-A1 CROSS-LINKING AGENT COMPOUND, LIQUID CRYSTAL ALIGNMENT COMPOSITION COMPRISING THE SAME, METHOD OF PREPARING LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY USING THE SAME LPXN, LIG4, MACF1 ALDH1A1 4249/4885HPGD 4697/4885MAPT 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.